agent

(redirected from neuromuscular blocking agent)
Also found in: Dictionary, Thesaurus, Medical, Legal, Financial, Acronyms, Wikipedia.

agent

a person representing a business concern, esp a travelling salesman

Agent

 

in Soviet civil law, a party in a contract of agency. The agent’s duties include the performance of specified legal acts, for example, contracts of sale and management of property, in the name of and on the account of a principal party. The agent may be a legally competent (sui juris) citizen or a legal person (if this is allowed by the latter’s charter or statute). The actions performed by the agent directly generate, change, or extinguish rights and obligations of the principal.

The agent is bound to perform the agency in exact conformity with the principal’s instructions, carry out the agency personally, although in instances provided for by law the responsibilities may be transferred to another person (art. 68 of the RSFSR Civil Code), inform the principal upon demand of progress in performing the agency, submit a report on performance of the agency, and transfer to the principal any property obtained in connection with performance of the agency.

agent

One who is empowered to enter into binding transactions on behalf of another (usually called the principal).

agent

(networking)
In the client-server model, the part of the system that performs information preparation and exchange on behalf of a client or server. Especially in the phrase "intelligent agent" it implies some kind of automatic process which can communicate with other agents to perform some collective task on behalf of one or more humans.

agent

A software routine that waits in the background and performs an action when a specified event occurs. For example, agents could transmit a summary file on the first day of the month or monitor incoming data and alert the user when a certain transaction has arrived. Agents are also called "intelligent agents," "personal agents" and "bots." See mobile agent, bot and workflow.
References in periodicals archive ?
Adverse effects of neuromuscular blocking agents based on yellow card reporting in the U.
In 1987, both houses of the New York Legislature overwhelmingly passed a bill to ban the use of "T-61, curare, any curariform drug, any neuromuscular blocking agent or any other paralyzing drug" in animal euthanasia, and allow animal shelters access to sodium pentobarbital.
Severe anaphylactic reactions to neuromuscular blocking agents, including ZEMURON, have been reported.
1-3) Therefore, general anesthesia (4,5) or local neuromuscular blocking agents (NMBA) have been used.
Neuromuscular blocking agent labelling and packaging initiative [Electronic version].
ICU patients receiving neuromuscular blocking agents should be observed clinically and blockade should be titrated to yield muscular twitch "train of four" testing at the level of one or two twitches.
Therefore Rocuronium almost fulfilling the criteria for ideal neuromuscular blocking agents for endotracheal intubation.
Neuromuscular blocking agents are most common agents leading to anaphylaxis perioperatively.
It was postulated that the use of the intermediate acting neuromuscular blocking agent would be associated with a lower incidence of residual neuromuscular block.
39 mg/kg in 50% of children during 5% sevoflurane and 60% nitrous oxide inhalation induction without a neuromuscular blocking agent.
This success was followed by the introduction of Norcuron in 1983 and in 1994 Zemuron/Esmeron was the first rapid onset non-depolarizing neuromuscular blocking agent to be introduced.
In 1994, Organon Teknika introduced the first rapid onset non-depolarizing neuromuscular blocking agent Zemuron(R) / Esmeron(R), which is today the most widely used muscle relaxant in the world.